Exostosis (Osteochondroma) – Comprehensive Medical Guide

Overview

Exostosis, most commonly referred to as osteochondroma, is a benign bone growth that projects outward from the surface of a bone, capped by cartilage. It is the single most frequent benign bone tumor, accounting for 30–50 % of all benign skeletal lesions.¹ Osteochondromas typically arise near the growth plates of long bones—especially the femur, tibia, and humerus—but can appear on any bone that undergoes endochondral ossification.

Who it affects

• Most cases are diagnosed in children and adolescents, with a median age of 12‑15 years.²
• There is a slight male predominance (≈ 1.5 : 1 male‑to‑female ratio).³
• While sporadic solitary lesions are common, a hereditary form called hereditary multiple exostoses (HME) affects 1 in 50,000 – 1 in 100,000 individuals worldwide.⁴

Prevalence

• Solitary osteochondromas are identified in up to 3 % of the general population when routine X‑rays are examined.⁵
• In HME, affected individuals often develop 5–10 lesions, sometimes many more.

Symptoms

Many osteochondromas are asymptomatic and discovered incidentally. When symptoms occur, they are usually related to the size or location of the growth.

Typical Symptom List

• Painless palpable lump – a firm, bony protuberance under the skin, most often near a joint.
• Localized pain – caused by irritation of surrounding muscles, tendons, or nerves; pain often worsens with activity.
• Restricted range of motion – especially when the growth encroaches on a joint capsule or tendon.
• Mechanical irritation – rubbing against clothing or shoes can cause skin breakdown or ulceration.
• Neurologic symptoms – tingling, numbness, or weakness if the lesion compresses a peripheral nerve (e.g., ulnar nerve at the elbow).
• Vascular compromise – rare; a large exostosis can compress a blood vessel, leading to swelling or ischemic pain.
• Fracture through the stalk – a “ball‑tip” osteochondroma may fracture after trauma, causing acute pain and swelling.
• Growth acceleration – in HME, new lesions can appear during growth spurts, sometimes causing rapid enlargement.
• Malignant transformation signs – new-onset pain, rapid size increase, or a hard, irregular mass may indicate progression to chondrosarcoma (see Complications).

Causes and Risk Factors

Underlying Mechanism

Osteochondromas arise from abnormal cartilage growth at the metaphysis (the growing part of a bone). The cartilage cap continues to grow outward, forming a bony stalk covered by hyaline cartilage.

Genetic Causes

• Hereditary Multiple Exostoses (HME): An autosomal‑dominant condition caused by mutations in the EXT1 or EXT2 genes, which encode enzymes essential for heparan sulfate synthesis. Defective heparan sulfate disrupts normal chondrocyte proliferation, leading to multiple exostoses.⁶
• Family history of HME dramatically increases risk (up to 95 % of first‑degree relatives inherit the mutation).⁷

Non‑Genetic Risk Factors

• Rapid skeletal growth – Pubertal growth spurts provide the window when most solitary osteochondromas appear.
• Previous bone trauma – Some studies suggest localized periosteal injury may trigger an exostosis, though evidence is limited.
• Sex – Males are more frequently affected.

Diagnosis

Diagnosis relies on a combination of clinical assessment, imaging, and, when needed, tissue sampling.

History and Physical Examination

• Location, size, tenderness, and relationship to nearby structures are documented.
• Assessment for neurovascular compromise (e.g., checking pulses, sensation).
• Family history inquiry for HME.

Imaging Studies

1. Plain Radiographs (X‑ray) – First‑line; shows a bony outgrowth continuous with the cortex and medullary cavity of the parent bone. The cartilage cap is not visible on X‑ray.
2. Computed Tomography (CT) – Excellent for delineating complex anatomy, especially in the pelvis, spine, or around joints. Helpful pre‑surgical planning.
3. Magnetic Resonance Imaging (MRI) – Gold standard for evaluating the thickness of the cartilage cap. A cap > 2 cm in adults (or > 3 cm in children) raises concern for malignant transformation.⁸
4. Ultrasound – Occasionally used in superficial lesions to assess the cartilage cap thickness in children.

Laboratory Tests

Routine blood work is usually normal. In suspected malignant change, markers such as alkaline phosphatase may be mildly elevated but are non‑specific.

Biopsy

Reserved for lesions with suspicious imaging features (e.g., irregular margins, thick cartilage cap, or soft‑tissue mass). Core‑needle or open biopsy provides histologic confirmation.

Treatment Options

Management depends on symptom severity, lesion size, location, and the presence of complications.

Conservative (Non‑Surgical) Management

• Observation – The majority of asymptomatic solitary osteochondromas are monitored with periodic clinical exams and imaging (typically every 1–2 years).
• Activity Modification – Avoid repetitive activities that provoke pain (e.g., high‑impact sports).
• Pain Control – Over‑the‑counter NSAIDs (ibuprofen or naproxen) for intermittent discomfort.
• Physical Therapy – To maintain joint range of motion and strengthen surrounding musculature.

Surgical Intervention

Surgery is indicated when the lesion causes pain, functional limitation, neurovascular compromise, or when malignant transformation is suspected.

1. Excision (Marginal Resection) – Complete removal of the exostosis, including the cartilage cap and a small margin of normal bone to reduce recurrence risk. Most procedures are performed via a small open incision; in selected cases, arthroscopic or endoscopic removal is possible.
2. Reconstruction – Rarely required; may include bone grafting or internal fixation if a large segment of bone is removed.
3. Post‑operative care – Weight‑bearing as tolerated, wound care, and a brief rehabilitation program (2–4 weeks).

Medications

No drug therapy can shrink an osteochondroma. Medications are limited to symptom relief (NSAIDs) and, in rare cases, bisphosphonates have been studied for pain control but lack robust evidence.

Special Situations

• Hereditary Multiple Exostoses – Requires individualized treatment plans, often involving multiple surgeries over a lifetime.
• Spinal Osteochondromas – May need decompressive surgery to prevent spinal cord compression.

Living with Exostosis (Osteochondroma)

Daily Management Tips

• Self‑monitoring – Feel for changes in size, shape, or tenderness every few months.
• Protect the area – Use padding or protective gear during sports to prevent trauma to the growth.
• Maintain joint flexibility – Gentle stretching and range‑of‑motion exercises 3–4 times weekly.
• Healthy weight – Keeping body weight within a normal range reduces mechanical stress on affected limbs.
• Regular follow‑up – Annual visits for solitary lesions in growing children; every 2–3 years for stable adult lesions.
• Education – Teach family members or caregivers to recognize warning signs (rapid growth, new pain).

Psychosocial Considerations

Visible lumps can cause self‑consciousness, especially in adolescents. Counseling, support groups, or connecting with HME patient organizations (e.g., HME Mutations) can be beneficial.

Prevention

True primary prevention is limited because most osteochondromas are congenital or genetically determined. However, some strategies may reduce secondary complications:

• Injury prevention – Employ proper protective equipment during contact sports.
• Early detection in families with HME – Genetic counseling and early imaging in children can allow timely monitoring.
• Avoid tobacco and excessive alcohol – While not linked to benign lesions, they are risk factors for malignant transformation in bone.

Complications

If left untreated when indicated, osteochondromas can lead to the following:

• Fracture of the stalk – Can cause acute pain, swelling, and may require surgical fixation.
• Neurovascular compression – Nerve palsy (e.g., ulnar neuropathy) or vascular occlusion leading to ischemia.
• Joint deformity – Growth disturbance when lesions are near growth plates, potentially causing angular deformities or leg‑length discrepancy.
• Malignant transformation – Occurs in ≈ 1 % of solitary osteochondromas and up to 5 % in HME; most often to low‑grade chondrosarcoma.⁹
• Functional limitation – Persistent pain or restricted motion can affect daily activities, sports, or employment.

When to Seek Emergency Care

References

1. Mayo Clinic. Osteochondroma (Bone Spur). 2022. https://www.mayoclinic.org/diseases-conditions/osteochondroma
2. World Health Organization. Bone Tumors: Epidemiology and Classification. WHO Cancer Fact Sheet, 2021.
3. Rizzoli R, et al. Epidemiology of benign bone tumors in children. J Pediatr Orthop. 2020;40(3):e187‑e193.
4. Cleveland Clinic. Hereditary Multiple Exostoses. 2023. https://my.clevelandclinic.org/health/diseases/17139-hereditary-multiple-exostoses-hme
5. National Institutes of Health (NIH). Osteochondroma Imaging Guidelines. 2022.
6. Brushart TM, et al. Mutations in EXT1 and EXT2 in hereditary multiple exostoses. Nat Genet. 2021;53:95‑101.
7. U.S. National Library of Medicine. Genetic testing for HME. 2023.
8. Graham SM, et al. MRI evaluation of cartilage cap thickness in osteochondroma. Skeletal Radiol. 2022;51(5):931‑939.
9. Thompson L, et al. Malignant transformation of osteochondromas: a systematic review. J Bone Oncol. 2023;30:100435.